Publications by Dr Stuart Bennett - ePrints

Browsing publications by Dr Stuart Bennett.

Newcastle Authors	Title	Year
Professor Simon Pearce Dr Anna Mitchell Dr Stuart Bennett Professor John Isaacs Dr Bijayeswar Vaidya et al.	Adrenal Steroidogenesis after B Lymphocyte Depletion Therapy in New-Onset Addison's Disease	2012
Professor Mark Walker Dr Muthu Jayapaul Dr Stuart Bennett	Erratum: Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects (Diabetologia http://dx.doi.org/10.1007/s00125-005-0004-7)	2006
Professor Mark Walker Dr Muthu Jayapaul Dr Stuart Bennett	Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects (vol 49, pg 1131, 2006)	2006
Dr Ibrahim Ibrahim Dr Ee Lim Dr Salman Razvi Professor Simon Pearce Dr Stuart Bennett et al.	Langerhans cell histiocytosis: management dilemma for the adult endocrinologist	2006
Professor Mark Walker Dr Muthu Jayapaul Dr Stuart Bennett	Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects	2005
Dr Carmela Ciardullo Dr Stuart Bennett Professor Mark Walker	Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance: Does it really work? If yes, is it a novelty?	2005
Dr Stuart Bennett Professor Mark Walker	Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance	2004
Professor Louise Parker Dr Douglas Lamont Professor Nigel Unwin Professor Mark Pearce Dr Stuart Bennett et al.	A lifecourse study of risk for hyperinsulinaemia, dyslipidaemia and obesity (the central metabolic syndrome) at age 49-51 years	2003
Professor Louise Parker Dr Douglas Lamont Professor Nigel Unwin Professor Mark Pearce Dr Stuart Bennett et al.	A lifecourse study of risk for hyperinsulinaemia, dyslipidaemia and obesity (the central metabolic syndrome) at age 49-51 years.[Erratum appears in Diabet Med. 2003 Sep;20(9):781]	2003
Dr Stuart Bennett Dr Richard Quinton	Congenital hypopituitarism presenting as adult-onset hypogonadotrophic hypogonadism	2002
Dr Stuart Bennett Professor Mark Walker	Rosiglitazone improves glycaemic and insulinaemic responses in subjects with impaired glucose tolerance	2001
Dr Stuart Bennett Professor Mark Walker	Rosiglitazone improves insulin sensitivity and 24-hour ambulatory blood pressure in subjects with IGT	2001
Dr Stuart Bennett Professor Mark Walker	Physical activity in non-diabetic relatives of type 2 diabetic patients	1999
Dr Douglas Lamont Professor Louise Parker Dr Stuart Bennett Professor Nigel Unwin Emeritus Professor Alan Craft et al.	Early life and later determinants of adult disease: A 50 year follow-up study of the Newcastle Thousand Families cohort	1998